Large pleural effusions occurring after coronary artery bypass grafting

Citation
Rw. Light et al., Large pleural effusions occurring after coronary artery bypass grafting, ANN INT MED, 130(11), 1999, pp. 891
Citations number
18
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
ANNALS OF INTERNAL MEDICINE
ISSN journal
00034819 → ACNP
Volume
130
Issue
11
Year of publication
1999
Database
ISI
SICI code
0003-4819(19990601)130:11<891:LPEOAC>2.0.ZU;2-X
Abstract
Background: Large pleural effusions sometimes occur after coronary artery b ypass grafting (CABG), but their characteristics and clinical course are la rgely unknown. Objective: To describe the clinical course and pleural fluid findings in pa tients with large pleural effusions occurring after CABG. Design: Retrospective case series. Setting: Tertiary care, university-affiliated, nonprofit teaching hospital. Patients: 3707 patients who had CABC between 1 February 1996 and 1 August 1 997. Measurements: Chest radiographs were reviewed, and information on pleural f luid findings, pleural effusion treatment, and cardiac surgery was obtained from medical records and a cardiac surgery database. Results: Pleural effusions that occupied more than 25% of the hemithorax we re found in 29 patients (0.78%). Seven of the effusions were attributed to congestive heart failure, 2 were attributed to pericarditis, and 1 was attr ibuted to pulmonary embolism. The explanation for the remaining 19 effusion s was unclear. All but 2 effusions were predominantly left-sided. Of these 19 effusions, 8 were bloody and 11 were nonbloody. Bloody effusions usually occurred earlier, contained higher lactic acid dehydrogenase levels, and w ere frequently eosinophilic. Nonbloody effusions tended to be more difficul t to manage. Conclusions: Large pleural effusions may develop in a small proportion of p atients after CABG. The cause of many of these effusions is unclear. Most b loody effusions can be managed with one to three therapeutic thoracenteses. Resolution of nonbloody effusions may require antiinflammatory agents, tub e thoracostomy, or intrapleural injection of sclerosing agents.